Aurora-A has been suggested to induce chemoresistance in several cancers by reducing apoptosis via activation of the NF-κB/miR-21/PTEN (phosphatase and tensin homolog) signaling pathway [73] and Akt through inhibition of the p53/PTEN cascade [74]. Here, TP53 is linked to cancer.